中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
22期
153-156
,共4页
中心静脉导管%胸腔闭式引流术%胸腔积液%气胸
中心靜脈導管%胸腔閉式引流術%胸腔積液%氣胸
중심정맥도관%흉강폐식인류술%흉강적액%기흉
Central venous catheter%Closed thoracic drainage%Pleural effusion%Pneumothorax
目的:观察中心静脉导管留置胸腔闭式引流术治疗各种胸腔积液和气胸的临床疗效和安全性。方法:用单腔中心静脉导管,长约30 cm硅胶引流管、引流瓶组成密闭的引流系统,对65例自发性气胸和76例中等量以上胸腔积液,包括外伤性血气胸或自发性液气胸37例、胸腔积液或恶性肿瘤伴胸腔积液39例,共计141例患者进行中心静脉导管闭式引流术。结果:胸腔积液有效率为94%;65例气胸除2例行切开闭式引流外,其余均治愈,有效率95%。结论:用单腔中心静脉导管、引流管、引流瓶组成的胸腔闭式引流是一种简便、有效、安全、可靠、患者容易接受的治疗胸腔积液和气胸的引流方法。
目的:觀察中心靜脈導管留置胸腔閉式引流術治療各種胸腔積液和氣胸的臨床療效和安全性。方法:用單腔中心靜脈導管,長約30 cm硅膠引流管、引流瓶組成密閉的引流繫統,對65例自髮性氣胸和76例中等量以上胸腔積液,包括外傷性血氣胸或自髮性液氣胸37例、胸腔積液或噁性腫瘤伴胸腔積液39例,共計141例患者進行中心靜脈導管閉式引流術。結果:胸腔積液有效率為94%;65例氣胸除2例行切開閉式引流外,其餘均治愈,有效率95%。結論:用單腔中心靜脈導管、引流管、引流瓶組成的胸腔閉式引流是一種簡便、有效、安全、可靠、患者容易接受的治療胸腔積液和氣胸的引流方法。
목적:관찰중심정맥도관류치흉강폐식인류술치료각충흉강적액화기흉적림상료효화안전성。방법:용단강중심정맥도관,장약30 cm규효인류관、인류병조성밀폐적인류계통,대65례자발성기흉화76례중등량이상흉강적액,포괄외상성혈기흉혹자발성액기흉37례、흉강적액혹악성종류반흉강적액39례,공계141례환자진행중심정맥도관폐식인류술。결과:흉강적액유효솔위94%;65례기흉제2례행절개폐식인류외,기여균치유,유효솔95%。결론:용단강중심정맥도관、인류관、인류병조성적흉강폐식인류시일충간편、유효、안전、가고、환자용역접수적치료흉강적액화기흉적인류방법。
To observe the clinical therapeutic effects and safety of central venous catheter in the treatment of pleural effusion and pneumothorax. Method:A closed drainage system by a single-lumen central venous line about 30 centimeters silicone sterilization drainage tube and one drainage bottle composition. A total of 141 patients were treated with central venous catheter for the closed drainage of thoracic cavity. It’s included 65 spontaneous pneumothorax patients and 76 medium pleural effusion patients. In 76 cases,there were 37 patients who were traumatic hemothora and hydropneumothorax. The others 39 patients were pleural effusions or malignant pleural effusions. Result:The total effective rate was 94%in pleural effusion patients. In 65 spontaneous pneumothorax patients,there were all cured except 2 cases with open closed drainage. It’s effective rate was 95%. Conclusion:The closed drainage system with central venous catheter,drainage tube and drainage bottle is simple,safe and effective method,to cure the pleural effusion and peumothorax,which is easy to be accepted by patients.